Mehul Kothari, a prominent stock market analyst from Anand Rathi, has suggested some promising investment opportunities for Indian investors. Kothari recommends purchasing stocks of BHEL, Astrazeneca Pharma, and Maruti Suzuki India. According to Kothari, these particular stocks exhibit favorable breakout patterns, indicating a potential increase in their prices. This advice comes at a crucial time for investors looking to capitalize on the current market trends. BHEL, a leading engineering and manufacturing company, Astrazeneca Pharma, a renowned pharmaceutical company, and Maruti Suzuki India, a well-established automobile manufacturer, are all poised for growth, making them attractive options for investors seeking to diversify their portfolios. Kothari’s recommendations are backed by thorough market research and analysis, making them worth considering for those looking to make informed investment decisions in the Indian stock market.